QC
IPSC icon

Quadrature Capital’s Century Therapeutics IPSC Stock Holding History

Quadrature Capital’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Buy
+45,890
New +$105K ﹤0.01% 1453

Other funds holding IPSC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AC
AXQ Capital Jersey City, New Jersey $920M AUM 18.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

Quadrature Capital's IPSC Position: Q2 2026 in Review

Quadrature Capital opened a new position in Century Therapeutics (IPSC) in Q2 2026: 45,890 shares worth $112K. The stake represents ﹤0.01% of the portfolio and ranks #1453 among its holdings.

21 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Quadrature Capital held 45,890 shares of Century Therapeutics worth $112K as of Q2 2026.
  • Century Therapeutics was a new Quadrature Capital position in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1453 holding.
  • 21 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.